help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 28, 2006
Endocrinology, doi:10.1210/en.2006-0967
A more recent version of this article appeared on April 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/4/1524    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dermitzaki, E.
Right arrow Articles by Margioris, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dermitzaki, E.
Right arrow Articles by Margioris, A. N.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

Submitted on July 19, 2006
Accepted on December 20, 2006

CORTICOTROPIN-RELEASING FACTOR (CRF) AND THE UROCORTINS DIFFERENTIALLY REGULATE CATECHOLAMINE SECRETION IN HUMAN AND RAT ADRENALS, IN A CRF RECEPTOR TYPE-SPECIFIC MANNER

E. Dermitzaki, C. Tsatsanis, V. Minas, E. Chatzaki, I. Charalampopoulos, M. Venihaki, A. Androulidaki, M. Lambropoulou, J. Spiess, E. Michalodimitrakis, A. Gravanis, and A. N. Margioris*

Departments of Clinical Chemistry-Biochemistry, Pharmacology, and Forensic Sciences, School of Medicine, University of Crete, Heraklion, Crete, Greece; Departments of Pharmacologyand Histology-Embryology, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece; Department of Neuroscience, J. Burns School of Medicine, University of Hawaii, Honolulu, USA

* To whom correspondence should be addressed. E-mail: andym{at}med.uoc.gr.

Corticotropin-Releasing Factor (CRF) affects catecholamine production both centrally and peripherally. Aim of the present work was to examine the presence of CRF, its related peptides, and their receptors in the medulla of human and rat adrenals and their direct effect on catecholamine synthesis and secretion. CRF, Urocortin I (UCN1), UCN2, and CRF receptor type I (CRF1) and CRF2 were present in human and rat adrenal medulla as well as in the PC12 pheochromocytoma cells by immunocytochemistry, immunofluorescence and RT-PCR. Exposure of dispersed human and rat adrenal chromaffin cells to CRF1 receptor agonists induced catecholamine secretion in a dose-dependent manner, an effect peaking at 30 min while CRF2 receptor agonists suppressed catecholamine secretion. The respective effects were blocked by CRF1 and CRF2 antagonists. CRF peptides affected catecholamine secretion via changes of subplasmaliminal actin filament polymerization. CRF peptides also affected catecholamine synthesis. In rat chromaffin and PC12 cells, CRF1 and CRF2 agonists induced catecholamine synthesis via tyrosine hydroxylase. However, in human chromaffin cells, activation of CRF1 receptors induced tyrosine hydroxylase while activation of CRF2 suppressed it. In conclusion, it appears that a complex intra-adrenal CRF-UCNs/CRF-receptor system exists in both human and rat adrenals controlling catecholamine secretion and synthesis.


Key words: CRF • Urocortins • catecholamines • adrenal







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society